New CAR T strategy targets most common form of heart disease

A pioneering preclinical study has shown that CAR T cell therapy—a personalized form of immunotherapy used in cancer treatment—could be a highly effective tool against atherosclerosis, the condition where a build-up of plaque in the arteries reduces blood flow, leading to heart attacks and strokes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup